ICU Medical, Inc. (ICUI) vs Relay Therapeutics, Inc. (RLAY)

A side-by-side comparison of ICU Medical, Inc. and Relay Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ICUI vs RLAY

growth of $100 · dividends reinvested · last 6y
ICUI -13.8% (-2.4%/yr)RLAY -44.7% (-9.4%/yr)ICUI compounded faster over this window
050100150Start $100202120222023202420252026$86$55
ICUI RLAY

ICUI vs RLAY: by the numbers

  • •RLAY is the larger company ($4.03B vs $3.95B market cap).
  • •ICUI is profitable (1.39% net margin) while RLAY runs a net loss (-2763.64%).
  • •ICUI grew revenue faster over the past five years (11.05% vs -34.29% CAGR).

Metrics side by side

Valuation

MetricICUIRLAY
P/E ratio134.05N/A
P/S ratio1.83389.37
P/B ratio1.844.53
EV / EBITDA13.55N/A
FCF yield3.87%N/A

Profitability

MetricICUIRLAY
Gross margin37.56%76.83%
Operating margin5.04%-1971.59%
Net margin1.39%-2763.64%
ROE1.40%-32.14%
ROIC3.11%-33.87%

Growth (annualized)

MetricICUIRLAY
Revenue CAGR (5Y)11.05%-34.29%
EPS CAGR (5Y)-62.79%N/A
FCF CAGR (5Y)-2.65%N/A
Total return CAGR (5Y)-7.18%-7.92%

Frequently asked

Which has grown faster, ICUI or RLAY?
Over the past five years, ICUI grew revenue faster — ICUI at a 11.05% CAGR versus RLAY at -34.29%.
Is ICUI or RLAY more profitable?
ICUI runs the higher net margin — ICUI at 1.39% versus RLAY at -2763.64%.
How have ICUI and RLAY total returns compared?
Over the past 5 years, ICUI delivered -7.18% and RLAY delivered -7.92% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.